ChemoCentryx Inc expected to post a loss of 55 cents a share - Earnings Preview

Churchill Capital XI

06/08/2021 22:33

* ChemoCentryx Inc  CCXI.OQ   CCXI.O  is expected to show a fall
in quarterly revenue when it reports results on August 9. 
* The San Carlos, California-based company is expected to report
  a 90.2% decrease in revenue to $4.847 million from $49.44
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for ChemoCentryx Inc is for
a loss of 55 cents per share. For the same quarter last year,
the company reported earnings of 29 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for ChemoCentryx
Inc is $30​, about 47.7% above​ its last closing price
of $15.69. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.42       -0.40      -0.43     Missed  -6.2
 Dec. 31 2020  -0.34       -0.33      -0.43     Missed  -29.2
 Sep. 30 2020  -0.31       -0.31      -0.35     Missed  -12.4​
 Jun. 30 2020  -0.34       -0.34      0.29      Beat    185.3
 Mar.          -0.30​      -0.30      -0.35     Missed  -16.7​
 31​ 2020​                                              
 Dec. 31 2019  -0.25       -0.26      -0.26     Met     0.6​
 Sep. 30 2019  -0.28       -0.28      -0.22     Beat    21.4
 Jun. 30 2019  -0.20       -0.22      -0.26     Missed  -20.5
 This summary was machine generated August 6 at 21:33 GMT.  All
figures in US dollars unless otherwise stated